BBVA USA Bancshares’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $252K | Sell |
1,305
-260
| -17% | -$50K | 0.01% | 503 |
|
|
2020
Q4 | $316K | Sell |
1,565
-174
| -10% | -$36K | 0.02% | 461 |
|
|
2020
Q3 | $365K | Sell |
1,739
-34
| -2% | -$7.57K | 0.02% | 413 |
|
|
2020
Q2 | $389K | Sell |
1,773
-172
| -9% | -$34.4K | 0.02% | 402 |
|
|
2020
Q1 | $337K | Sell |
1,945
-8
| -0.4% | -$1.32K | 0.02% | 386 |
|
|
2019
Q4 | $300K | Buy |
+1,953
| New | +$292K | 0.02% | 451 |
|
|
2019
Q3 | – | Sell |
-1,908
| Closed | -$292K | – | 400 |
|
|
2019
Q2 | $292K | Sell |
1,908
-15
| -0.8% | -$2.29K | 0.02% | 456 |
|
|
2019
Q1 | $308K | Sell |
1,923
-7
| -0.4% | -$1.09K | 0.02% | 437 |
|
|
2018
Q4 | $297K | Sell |
1,930
-28
| -1% | -$4.36K | 0.02% | 421 |
|
|
2018
Q3 | $295K | Buy |
1,958
+34
| +2% | +$4.83K | 0.02% | 464 |
|
|
2018
Q2 | $260K | Sell |
1,924
-341
| -15% | -$42.1K | 0.02% | 475 |
|
|
2018
Q1 | $302K | Sell |
2,265
-558
| -20% | -$74.9K | 0.02% | 454 |
|
|
2017
Q4 | $420K | Sell |
2,823
-205
| -7% | -$27.9K | 0.03% | 398 |
|
|
2017
Q3 | $399K | Sell |
3,028
-66
| -2% | -$8.87K | 0.03% | 407 |
|
|
2017
Q2 | $413K | Sell |
3,094
-12
| -0.4% | -$1.62K | 0.03% | 399 |
|
|
2017
Q1 | $419K | Sell |
3,106
-59
| -2% | -$7.64K | 0.03% | 394 |
|
|
2016
Q4 | $380K | Sell |
3,165
-256
| -7% | -$30.2K | 0.03% | 415 |
|
|
2016
Q3 | $428K | Sell |
3,421
-86
| -2% | -$11.3K | 0.03% | 377 |
|
|
2016
Q2 | $486K | Sell |
3,507
-1,120
| -24% | -$145K | 0.04% | 349 |
|
|
2016
Q1 | $583K | Sell |
4,627
-656
| -12% | -$83.4K | 0.04% | 337 |
|
|
2015
Q4 | $670K | Buy |
5,283
+250
| +5% | +$31K | 0.05% | 294 |
|
|
2015
Q3 | $582K | Buy |
5,033
+276
| +6% | +$31K | 0.05% | 298 |
|
|
2015
Q2 | $495K | Sell |
4,757
-188
| -4% | -$20.3K | 0.03% | 358 |
|
|
2015
Q1 | $546K | Buy |
4,945
+18
| +0.4% | +$1.95K | 0.02% | 368 |
|
|
2014
Q4 | $514K | Sell |
4,927
-161
| -3% | -$16.1K | 0.02% | 386 |
|
|
2014
Q3 | $489K | Buy |
5,088
+32
| +0.6% | +$2.89K | 0.02% | 392 |
|
|
2014
Q2 | $462K | Buy |
5,056
+272
| +6% | +$24.4K | 0.02% | 402 |
|
|
2014
Q1 | $421K | Buy |
4,784
+494
| +12% | +$43.4K | 0.02% | 406 |
|
|
2013
Q4 | $397K | Buy |
4,290
+425
| +11% | +$38.3K | 0.02% | 407 |
|
|
2013
Q3 | $316K | Sell |
3,865
-772
| -17% | -$65.2K | 0.02% | 421 |
|
|
2013
Q2 | $386K | Buy |
+4,637
| New | +$399K | 0.02% | 344 |
|
Other funds holding CLX
CRC
BBVA USA Bancshares's CLX Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Clorox (CLX) stake by 17% in Q1 2021, selling an estimated $50K and leaving 1,305 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #503.
BBVA USA Bancshares first reported a position in CLX in Q2 2013 and has held it in 31 quarters since. The position peaked at $670K in Q4 2015. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.
- BBVA USA Bancshares held 1,305 shares of Clorox worth $252K as of Q1 2021.
- BBVA USA Bancshares sold 260 Clorox shares in Q1 2021, an estimated $50K.
- Clorox made up 0.01% of BBVA USA Bancshares's portfolio in Q1 2021, its #503 holding.
- BBVA USA Bancshares first reported a position in Clorox in Q2 2013 and has held it in 31 quarters since.
- BBVA USA Bancshares's Clorox position peaked at $670K in Q4 2015.
- 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.